Corbus Pharmaceuticals Hldgs Inc (CRBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -71,454 | -44,873 | -24,082 | -26,235 | -55,672 |
| Depreciation Amortization | 1,230 | 825 | 541 | 153 | 494 |
| Accounts receivable | 5,000 | 5,000 | 5,000 | N/A | 12,500 |
| Accounts payable and accrued liabilities | 4,366 | -836 | 1,098 | 2,451 | 3,904 |
| Other Working Capital | 12,476 | 11,890 | 11,563 | 33,298 | 17,009 |
| Other Operating Activity | 2,661 | 4,836 | -192 | 652 | -8,302 |
| Operating Cash Flow | $-45,721 | $-23,159 | $-6,072 | $10,318 | $-30,067 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,743 | -1,451 | -257 | -74 | -2,300 |
| Investing Cash Flow | $-2,743 | $-1,451 | $-257 | $-74 | $-2,300 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 964 | N/A | N/A | N/A | N/A |
| Debt Issued | N/A | N/A | N/A | -147 | 492 |
| Debt Repayment | 0 | -395 | -295 | 0 | -434 |
| Common Stock Issued | 40,677 | 40,677 | 40,597 | 40,494 | 12,053 |
| Other Financing Activity | -3,177 | -2,572 | -2,566 | -2,420 | -690 |
| Financing Cash Flow | $38,464 | $37,711 | $37,736 | $37,927 | $11,420 |
| Beginning Cash Position | 41,749 | 41,749 | 41,749 | 41,749 | 62,697 |
| End Cash Position | 31,749 | 54,849 | 73,155 | 89,920 | 41,749 |
| Net Cash Flow | $-10,000 | $13,101 | $31,407 | $48,171 | $-20,948 |
| Free Cash Flow | |||||
| Operating Cash Flow | -45,721 | -23,159 | -6,072 | 10,318 | -30,067 |
| Capital Expenditure | -2,743 | -1,451 | -257 | -74 | -2,300 |
| Free Cash Flow | -48,463 | -24,610 | -6,329 | 10,245 | -32,368 |